Michael Severino

Companies

• Sarepta TherapeuticsBoard member Jul 29, 2026 to now¹
• Sarepta TherapeuticsChief executive officer Jul 29, 2026 to now¹
• ViatrisBoard member May 13, 2025 to now²
• AvantorBoard member Apr 24, 2020 to now³
• AbbVieEVP, R&D and CSO Jun 4, 2014 to May 25, 2022⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AbbVie ABBV152,103 shares⁵$43.4M at $285.03May 23, 2022
• Sarepta Therapeutics SRPT756,104 shares⁶$13.5M at $17.79Jul 28, 2026
• AAvantor AVTR85,821 shares⁷$1.4M at $16.42May 7, 2026
• Viatris VTRS26,031 shares⁸$485.2K at $18.64Mar 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 28, 2026Granted 756,104 shares of Sarepta Therapeutics⁶
• May 7, 2026Granted 25,270 shares of Avantor⁷
• Mar 6, 2026Exercised options 919 shares of Viatris⁸
• Mar 6, 2026Exercised options 25,112 shares of Viatris⁸
• May 8, 2025Granted 17,100 shares of Avantor⁹
• May 9, 2024Granted 8,477 shares of Avantor¹⁰
• May 11, 2023Granted 9,808 shares of Avantor¹¹
• May 23, 2022Sold 11,605 shares at $151.53 of AbbVie⁵
• May 23, 2022Sold 68,196 shares at $150.79 of AbbVie⁵
• May 23, 2022Exercised options 21,739 shares at $105.92 of AbbVie⁵
• May 23, 2022Exercised options 11,742 shares at $93.50 of AbbVie⁵
• May 23, 2022Exercised options 46,320 shares at $114.36 of AbbVie⁵
• May 17, 2022Sold 2,100 shares at $155.27 of AbbVie¹²
• May 17, 2022Sold 54,279 shares at $154.49 of AbbVie¹²
• May 17, 2022Sold 43,621 shares at $153.43 of AbbVie¹²
• May 17, 2022Exercised options 64,636 shares at $93.50 of AbbVie¹²
• May 17, 2022Exercised options 35,364 shares at $79.02 of AbbVie¹²
• May 16, 2022Sold 400 shares at $155.44 of AbbVie¹²
• May 16, 2022Sold 53,327 shares at $154.80 of AbbVie¹²
• May 16, 2022Sold 46,273 shares at $154.04 of AbbVie¹²
• May 16, 2022Exercised options 29,121 shares at $79.02 of AbbVie¹²
• May 16, 2022Exercised options 70,879 shares at $61.36 of AbbVie¹²
• May 12, 2022Granted 6,693 shares of Avantor¹³
• May 10, 2022Sold 48,591 shares at $152.83 of AbbVie¹⁴
• May 10, 2022Sold 28,536 shares at $152.24 of AbbVie¹⁴